Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Guggul Lipid Solid Lipid Nanoparticles as a Promising Drug Carrier for Transdermal Drug Delivery

Hitesh Kifle

Diclofenac sodium-loaded solid lipid nanoparticles with guggul lipid as the main lipid component were created and tested for physical characteristics, permeation profile, and anti-inflammatory action. The SLNs were formed into gel after being assessed for physical parameters, in vitro drug release, and accelerated stability experiments. For ex vivo and in vivo drug penetration and anti-inflammatory effectiveness, the gels were compared to a commercial emulgel and a plain carbopol gel containing drug. The SLNs were stable and had ideal physical properties. The maximum in vitro drug release was achieved by GMS nanoparticle 1 and stearic acid nanoparticle 1. In receptor fluid, guggul lipid nanoparticle gel 3 had 104.68 times more drug than CEG. The enhancement ratio of GLNG-3 in comparison to CG was 39.43. At 4 hours, GLNG-3 was over 8.12 times greater than CEG. The AUC of GLNG-3 was 15.28 times greater than that of CEG.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.